2nd Quarter - Report

TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to pharmacy and prescription drug pricing; Issues relating to implementation of the No Surprises Act (PL 116-260); Issues related to price transparency.

LobbyistCovered position, as disclosed
JAN BEUKELMAN —
NIKOLE BURROUGHS —
ANDREW MCKECHNIE —
JOSEPH RUSSO —
JOHN KIRKLAND TWOMEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.

LobbyistCovered position, as disclosed
JAN BEUKELMAN —
NIKOLE BURROUGHS —
ANDREW MCKECHNIE —
JOSEPH RUSSO —
JOHN KIRKLAND TWOMEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4784 (119th), H.R. 8800 (119th)

Pharmacy PHA

Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.

LobbyistCovered position, as disclosed
JAN BEUKELMAN —
NIKOLE BURROUGHS —
ANDREW MCKECHNIE —
JOSEPH RUSSO —
JOHN KIRKLAND TWOMEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2355 (119th), H.R. 5582 (119th)

Medicare/Medicaid MMM

Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.

LobbyistCovered position, as disclosed
JAN BEUKELMAN —
NIKOLE BURROUGHS —
ANDREW MCKECHNIE —
JOSEPH RUSSO —
JOHN KIRKLAND TWOMEY —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.